Fineline Cube

Follow:
14737 Articles
Company

Shanghai Pharmaceuticals Posts 13.11% YOY Revenue Growth in Q3 2023 Financials

CompanyDeals

Shanghai Henlius Biotech and Intas Pharmaceuticals Ink New Licensing Deal for PD-1 mAb

CompanyDrug

GSK’s ViiV Healthcare Secures NMPA Approval for Vocabria in HIV-1 Treatment

CompanyDrug

AbbVie’s Rinvoq Gains Two New Indications in China: AxSpA and Ankylosing Spondylitis

Company

Takeda’s Global Revenues Grow: Strong Performance in Plasma Therapies and Gastroenterology

Company

BMS Revenue Slips Due to Revlimid Erosion: Q3 2023 Insights

CompanyDrug

Eli Lilly’s Omvoh Receives FDA Approval for Ulcerative Colitis Treatment

Company

Merck Reports 9% Global Sales Growth in Q3 2023, Boosted by Keytruda and Gardasil

CompanyDeals

Strategic Alliance Formed by uBriGene, Fraserna, and Virogin for Cell and Gene Therapy Services

CompanyDrug

Fujian Cosunter Gains Ethical Approval for Phase IIa Study of GST-HG131 in Hepatitis B

CompanyDrug

Abbisko Therapeutics Gets NMPA Approval for Phase I Study of ABSK112 in NSCLC

Policy / Regulatory

NMPA Unveils 73rd Batch of Reference Drugs for Generic Quality Consistency